Strontium ranelate
Key facts
Invented name |
Osseor
|
Active substance |
strontium ranelate
|
Therapeutic area |
Immunology-Rheumatology-Transplantation
|
Decision number |
P/24/2010
|
PIP number |
Strontium ranelate
|
Pharmaceutical form(s) |
Granules for oral suspension
|
Condition(s) / indication(s) |
Osteoporosis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Les Laboratoires Servier
E-mail: mail.pip.enquiries@servier.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|